Silver Book Fact

Diabetes drug expenditures rose from $6.7 billion in 2001 to $12.5 billion in 2007.

Alexander G, Sehgal N, Moloney R, Stafford R. National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007. Arch Intern Med. 2008; 168(19): 2088-94. http://archinte.jamanetwork.com/article.aspx?articleid=773439

Reference

Title
National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007
Publication
Arch Intern Med
Publication Date
2008
Authors
Alexander G, Sehgal N, Moloney R, Stafford R
Volume & Issue
Volume 168, Issue 19
Pages
2088-94
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • 44,400 diabetics began treatment for end-stage renal disease (ESRD) in 2002.  
  • Medicare beneficiaries with diabetic macular edema (DME) had 31% higher 1-year costs and 29% higher 3-year costs compared to diabetic Medicare beneficiaries without DME.  
  • Between 2005 and 2008, 4.2 million adults age 40 and older had diabetic retinopathy.  
  • In 2002, diabetes mellitus caused 73,249 deaths.  
  • Diabetes is costly, accounting for one-tenth of US health care expenditures in 2007.